A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Adil Daud, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Adil Daud, MD
Professor, Medicine, School of Medicine. Authored (or co-authored) 208 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Seagen Inc.
- ID
- NCT05571839
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 275 study participants
- Last Updated